Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V21822 | GSK1723980 | 1244641-64-2 | GSK1723980 is a novel and potent inhibitor of rTbIPMK |
![]() |
V21823 | GSK172981 | 1133705-99-3 | GSK172981 is a novel and potent non-peptide tachykinin NK3 receptor antagonist |
![]() |
V21824 | GSK1733953A | 930470-97-6 | DG70 (GSK1733953A) is a benzidine, a respiratory inhibitor of Mycobacterium tuberculosis (TB), inhibiting MenG activity with IC50 of 2.6 ± 0.6 μM. |
![]() |
V21825 | GSK1795091 | 1233589-81-5 | GSK1795091 (CRX-601;GSK-1795091) is a novel and potent Toll-like receptor 4 (TLR4) agonist with antitumor activity. |
![]() |
V21827 | GSK1829820A | 1443138-52-0 | GSK1829820A is a novel and potent inhibitor of Mycobacterium tuberculosis H37Rv. |
![]() |
V21828 | GSK1842799 | 1005407-76-0 | GSK1842799 is a novel and potent S1P1 receptor agonist |
![]() |
V7968 | GSK199 | 1549811-53-1 | GSK199 is a reversible and selective PAD4 inhibitor (antagonist) with IC50 of 200 nM in the absence of calcium ions. |
![]() |
V21829 | GSK1997132B | 1168138-37-1 | GSK1997132B is a novel and potent PPARγ agonist |
![]() |
V7676 | GSK2008607 | 1244644-50-5 | GSK2008607 is a novel and potent inhibitor of rTbIPMK |
![]() |
V21832 | GSK2163632A | 1123163-20-1 | GSK2163632A is a novel and potent insulin-like growth factor 1 receptor inhibitor |
![]() |
V21833 | GSK2188764 | 1849587-68-3 | GSK2188764 is a novel and potent nhibitor of T. |
![]() |
V21834 | GSK2210875 | 1170668-67-3 | GSK2210875 is a novel and potent mGluR5 antagonist |
![]() |
V21835 | GSK223 | 899758-61-3 | GSK223 is a novel and potent inhibitor of IL-8 |
![]() |
V21836 | GSK2239633 | 2181665-31-4 | GSK2239633 (GSK-2239633) is a novel and potent CC-chemokine receptor 4 antagonist with anti-inflammatory activity. |
![]() |
V21839 | GSK2245035 | 1207629-49-9 | GSK2245035 (GSK-2245035) is a novel potent andselective intranasalToll-like receptor 7 (TLR7) agonistwith Type-1 interferon (IFN)-stimulating activity and the potential to be used for the treatment of asthma. |
![]() |
V21841 | GSK2256294 HCl | GSK2256294 HCl is a novel and potent inhibitor of sEH | |
![]() |
V21843 | GSK2263167 | 1165924-28-6 | GSK2263167 is an S1P1 receptor agonist (activator). |
![]() |
V21432 | GSK2324 | 1020567-30-9 | GSK2324 (GSK-2324) is a novel and potent FXR agonist that has the potentialto treat non-alcoholic fatty liver disease (NAFLD), in part because they reducehepatic lipids. |
![]() |
V21849 | GSK256073 | 802892-90-8 | GSK256073 is a potent, selective, orally bioactive GPR109A agonist and a durable HCA2 agonist with pEC50 of 7.5 (Human HCA2). |
![]() |
V21848 | GSK256073 | 862892-90-8 | GSK256073 is a potent, selective, orally bioactive GPR109A agonist and a durable HCA2 agonist with pEC50 of 7.5 (Human HCA2). |